Aurinia Pharmaceuticals Inc. (AUPH) › Operating Cash FlowAurinia Pharmaceuticals Inc. (AUPH) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -$51.61M2019: -$63.59M2020: -$69.86M2021: -$157.69M2022: -$79.53M2023: -$33.46M2024: $44.39M2025: $135.66M$135.66M2018Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$135.66M+205.6%2024$44.39M+232.7%2023-$33.46M+57.9%2022-$79.53M+49.6%2021-$157.69M-125.7%2020-$69.86M-9.9%2019-$63.59M-23.2%2018-$51.61M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share